Literature DB >> 25605260

Features of infratentorial-predominant posterior reversible encephalopathy syndrome.

Ryan T Fitzgerald1, Rohan S Samant2, Manoj Kumar2, Rudy Van Hemert2, Edgardo J Angtuaco2.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a neurotoxic process that typically occurs in the setting of immune dysregulation. In contrast to the characteristic pattern involving parieto-occipital and posterior frontal regions, predominant involvement of the infratentorial brain occurs in a minority of PRES patients. We examined six patients with infratentorial predominant posterior reversible encephalopathy syndrome (IPPRES) relative to those with typical PRES in terms of clinical factors of toxicity and outcomes. We review the current understanding of PRES pathophysiology. An institutional database of PRES patients was created through an IRB-approved search of the electronic record from 2007 to 2012. MR images were reviewed and classified by two neuro radiologists. Clinical data including laboratory data, blood pressure, and discharge outcome were collected through review of existing electronic medical records. Characteristics of the two groups were compared. Six cases among 80 PRES patients displayed an atypical distribution of signal abnormality predominantly involving the infratentorial brain. In IPPRES patients, signal abnormalities within the supratentorial brain, when present, showed a predominantly central distribution rather than the typical peripheral distribution. IPPRES patients showed higher rates of extreme hypertension, renal dysfunction, abnormal serum calcium, and abnormal serum magnesium relative to typical PRES patients. Outcomes were similar between the two groups. In our small series, IPPRES differs from typical PRES patients not only in the distribution of imaging abnormalities but also in rates of extreme hypertension and several laboratory indices. Despite these differences, clinical outcome in the IPPRES group was similar to that of typical PRES.

Entities:  

Keywords:  Brainstem; Cerebellum; Hypertensive encephalopathy; PRES; Posterior reversible encephalopathy syndrome

Mesh:

Year:  2015        PMID: 25605260      PMCID: PMC4510038          DOI: 10.1007/s13760-015-0431-2

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  21 in total

Review 1.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 2.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

3.  Severe hypomagnesemia associated with reversible subacute ataxia and cerebellar hyperintensities on MRI.

Authors:  Mark I Boulos; Ashkan Shoamanesh; Richard I Aviv; David J Gladstone; Richard H Swartz
Journal:  Neurologist       Date:  2012-07       Impact factor: 1.398

4.  Posterior reversible encephalopathy syndrome (PRES) with immune system activation, VEGF up-regulation, and cerebral amyloid angiopathy.

Authors:  Julia Kofler; Walter S Bartynski; Thomas Q Reynolds; Frank S Lieberman; Geoffrey H Murdoch; Ronald L Hamilton
Journal:  J Comput Assist Tomogr       Date:  2011 Jan-Feb       Impact factor: 1.826

5.  Neuropathology of a fatal case of posterior reversible encephalopathy syndrome.

Authors:  John N Kheir; Michael W Lawlor; Edward S Ahn; Leslie Lehmann; James J Riviello; V Michelle Silvera; Michael McManus; Rebecca D Folkerth
Journal:  Pediatr Dev Pathol       Date:  2010-02-16

6.  Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features.

Authors:  H M Hefzy; W S Bartynski; J F Boardman; D Lacomis
Journal:  AJNR Am J Neuroradiol       Date:  2009-04-22       Impact factor: 3.825

7.  Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome.

Authors:  W S Bartynski; J F Boardman
Journal:  AJNR Am J Neuroradiol       Date:  2007-12-13       Impact factor: 3.825

8.  Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia.

Authors:  Justin Brewer; Michelle Y Owens; Kedra Wallace; Amanda A Reeves; Rachael Morris; Majid Khan; Babbette LaMarca; James N Martin
Journal:  Am J Obstet Gynecol       Date:  2013-02-07       Impact factor: 8.661

9.  Elucidating the mechanism of posterior reversible encephalopathy syndrome: a case of transient blindness after central venous catheterization.

Authors:  Neal M Rao; Radoslav Raychev; Doojin Kim; David S Liebeskind
Journal:  Neurologist       Date:  2012-11       Impact factor: 1.398

10.  Determinants of recovery from severe posterior reversible encephalopathy syndrome.

Authors:  Stephane Legriel; Olivier Schraub; Elie Azoulay; Philippe Hantson; Eric Magalhaes; Isaline Coquet; Cedric Bretonniere; Olivier Gilhodes; Nadia Anguel; Bruno Megarbane; Laurent Benayoun; David Schnell; Gaetan Plantefeve; Julien Charpentier; Laurent Argaud; Bruno Mourvillier; Arnaud Galbois; Ludivine Chalumeau-Lemoine; Michel Rivoal; François Durand; Arnaud Geffroy; Marc Simon; Annabelle Stoclin; Jean-Louis Pallot; Charlotte Arbelot; Martine Nyunga; Olivier Lesieur; Gilles Troché; Fabrice Bruneel; Yves-Sébastien Cordoliani; Jean-Pierre Bedos; Fernando Pico
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

View more
  4 in total

Review 1.  Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

Review 2.  Isolated pons involvement in Posterior Reversible Encephalopathy Syndrome: Case report and review of the literature.

Authors:  Mariangela Ferrara; Pietro Di Viesti; Vincenzo Inchingolo; Raffaela Rita Latino; Teresa Popolizio; Salvatore Angelo De Cosmo; Flavia Pugliese; Maurizio Angelo Leone
Journal:  eNeurologicalSci       Date:  2016-11-28

3.  Diffuse leukoencephalopathy in a 29-year-old male with hypertensive emergency.

Authors:  Ghada Issa; Samer Nasser; Samir Kodsi; Zein Farhat
Journal:  BJR Case Rep       Date:  2016-11-02

4.  Posterior Reversible Encephalopathy Syndrome With Isolated Involving Infratentorial Structures.

Authors:  Shuchun Ou; Lu Xia; Li Wang; Li Xia; Qin Zhou; Songqing Pan
Journal:  Front Neurol       Date:  2018-10-09       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.